GPX4 and pulmonary fibrosis: Liproxstatin-1, an ferroptosis inhibitor, delayed fibroblast differentiation into myofibroblasts and reduced pulmonary fibrosis by limiting collagen deposition and decreasing GPX4 expression (138, 139).